OAC
AMAG

OMERS Administration Corp’s AMAG Pharmaceuticals AMAG Stock Holding History

OMERS Administration Corp’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-15,600
Closed -$543K – 411
2016
Q4 		$543K Hold
15,600
– – 0.01% 224
2016
Q3 		$382K Sell
15,600
-11,200
-42% -$280K 0.01% 513
2016
Q2 		$641K Buy
+26,800
New +$614K 0.01% 404
2015
Q3 		– Sell
-21,000
Closed -$1.45M – 517
2015
Q2 		$1.45M Hold
21,000
– – 0.06% 213
2015
Q1 		$1.15M Hold
21,000
– – 0.04% 204
2014
Q4 		$895K Hold
21,000
– – 0.03% 260
2014
Q3 		$670K Sell
21,000
-7,300
-26% -$156K 0.02% 282
2014
Q2 		$586K Buy
+28,300
New +$523K 0.02% 308

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

OMERS Administration Corp's AMAG Position: Q1 2017 in Review

OMERS Administration Corp sold out of AMAG Pharmaceuticals (AMAG) in Q1 2017, closing a stake of 15,600 shares — an estimated $543K sold.

OMERS Administration Corp first reported a position in AMAG in Q2 2014 and held it in 8 quarters. The position peaked at $1.45M in Q2 2015. 185 funds tracked by Wall St. Rank hold AMAG as of Q1 2017.

  • OMERS Administration Corp reported no remaining AMAG Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • OMERS Administration Corp sold 15,600 AMAG Pharmaceuticals shares in Q1 2017, an estimated $543K.
  • OMERS Administration Corp first reported a position in AMAG Pharmaceuticals in Q2 2014 and held it in 8 quarters.
  • OMERS Administration Corp's AMAG Pharmaceuticals position peaked at $1.45M in Q2 2015.
  • 185 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2017.

Based on OMERS Administration Corp's 13F filing for Q1 2017, filed 10 May 2017.